Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T14:10:50.165Z.
Calculation as of: 2026-10-06T14:10:50.165Z.
Quote observation: 2026-10-06T14:08:49.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 83c64da899843448fde498cf5e629ee28b7cf55c7878198a0aebccb75d14602d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2022-05-16.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
OPERATING CASH FLOW YIELD AVG TTM
N/A
OPERATING CASH FLOW YIELD AVG 3Y
N/A
OPERATING CASH FLOW YIELD AVG 5Y
N/A
OPERATING CASH FLOW YIELD AVG 10Y
N/A
OPERATING CASH FLOW YIELD AVG 15Y
N/A
OPERATING CASH FLOW YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Aspire Biopharma Holdings, Inc.
Market Cap
$1.02M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.06M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.10M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$889929.00
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$885727.00
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$898130.00
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.18M
Operating Cash Flow Yield
N/A
TTM Avg
48.56%
3Y Avg
48.84%
5Y Avg
48.84%
Market Cap
$814941.00
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.20M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | $1.02M | N/A | N/A | N/A | N/A |
| Clearmind Medicine Inc. (CMND)vs › | $1.06M | N/A | N/A | N/A | N/A |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.10M | N/A | N/A | N/A | N/A |
| GlucoTrack, Inc. (GCTK)vs › | $889929.00 | N/A | N/A | N/A | N/A |
| Decoy Therapeutics Inc. (DCOY)vs › | $885727.00 | N/A | N/A | N/A | N/A |
| Bone Biologics Corporation (BBLG)vs › | $898130.00 | N/A | N/A | N/A | N/A |
| IM Cannabis Corp. (IMCC)vs › | $1.18M | N/A | 48.56% | 48.84% | 48.84% |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $814941.00 | N/A | N/A | N/A | N/A |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.20M | N/A | N/A | N/A | N/A |
| Genprex, Inc. (GNPX)vs › | $1.33M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING CASH FLOW YIELD |
|---|---|
| 2022-05-16 | 0.00% |
| 2022-05-13 | 0.00% |
| 2022-05-12 | 0.00% |
| 2022-05-11 | 0.00% |
| 2022-05-10 | 0.00% |
| 2022-05-09 | 0.00% |
| 2022-05-06 | 0.00% |
| 2022-05-05 | 0.00% |
| 2022-05-04 | 0.00% |
| 2022-05-03 | 0.00% |
| 2022-05-02 | 0.00% |
| 2022-04-29 | 0.00% |
| 2022-04-28 | 0.00% |
| 2022-04-27 | 0.00% |
| 2022-04-26 | 0.00% |
| 2022-04-25 | 0.00% |
| 2022-04-22 | 0.00% |
| 2022-04-21 | 0.00% |
| 2022-04-20 | 0.00% |
| 2022-04-19 | 0.00% |
| 2022-04-18 | 0.00% |
| 2022-04-14 | 0.00% |
| 2022-04-13 | 0.00% |
| 2022-04-12 | 0.00% |
| 2022-04-11 | 0.00% |
